Ipsen S.A (IPN) | Stock Overview & Key Data
Ipsen S.A. | Large-cap | Healthcare
Ipsen S.A. | Large-cap | Healthcare
Ipsen S.A Performance Comparison
Stock Range
Today's Range
Low: €114.60
High: €116.70
on October 6, 2025
52 Week Range
Low: €87.95
High: €125.60
on April 22, 2025
on January 17, 2025
All-Time High: €155.95 on September 10, 2018
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€9.7B
EPS
5.37
P/E Ratio (TTM)
21.64
Forward P/E
11.47
P/B Ratio
2.27
PEG Ratio
11.47
Div. Yield
1.38%
ROE
10.89%
Beta
0.197
Debt to Equity
22.74
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
26.17%
Profit Margin
11.91%
Returns and Earnings
Return on Assets (TTM)
9.58%
Return on Equity (TTM)
10.89%
EBITDA
€1.4B
Net Income (TTM)
€447.9M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€45.46
Quarterly Revenue Growth (YoY)
10.60%
Quarterly Earnings Growth (YoY)
44.00%
Dividend Information
Last 12-Month Dividend
€1.40
Current Dividend Yield
1.38%
3-Year Average Dividend Yield
1.14%
3-Year Average Annual Dividend
€1.27
3-Year Total Dividends
€3.80
Ex-Dividend Date
June 4, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Ipsen S.A IPN | 9.72B Large-cap | 4.12% | -0.94% | 13.70% | 7.79% | 2.74% | 2.02% | 14.82% | 39.33% |
| Vetoquinol S.A VETO | 926.25M Mid-cap | 1.68% | 8.56% | 4.11% | 1.95% | 3.42% | -7.53% | -8.18% | 1.29% |
| Boiron S.A BOI | 468.55M Mid-cap | -8.75% | 21.18% | 18.49% | 5.77% | -0.56% | -16.48% | -43.16% | -39.27% |
| Euroapi S.A.S.U EAPI | 312.68M Mid-cap | 12.33% | 10.44% | 6.15% | 26.15% | 10.44% | -9.64% | -81.18% | -75.72% |
| AB Science S.A AB | 85.89M Small-cap | 5.60% | 7.32% | -10.20% | -2.94% | 46.67% | 33.33% | -82.83% | -87.66% |
| CoreTech Limited MLCOT | 2.18M Small-cap | 0.00% | -38.10% | -67.50% | 225.00% | 1,200.00% | 550.00% | 225.00% | 225.00% |
Ownership & Short Interest
Insider Ownership
57.22%
Institutional Ownership
15.31%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
70K
Average 90-Day Volume
76K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is IPN's 52-week high and low?
- In the last 52 weeks, Ipsen S.A reached a high of €125.60 (on January 17, 2025) and a low of €87.95 (on April 22, 2025).
- What is the market cap and P/E ratio for IPN?
- Curious about Ipsen S.A's size and valuation? Its market capitalization stands at 9.72B. When it comes to valuation, the P/E ratio (trailing twelve months) is 21.64, and the forward P/E (looking ahead) is 11.47.
- Does IPN pay dividends? If so, what's the yield?
- Yes, Ipsen S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.38%, and the company has paid an average of €1.27 per share annually over the past 3 years.
- Who are Ipsen S.A's main competitors or similar companies to consider before investing?
When looking at Ipsen S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Vetoquinol S.A
VETO926.25M Healthcare Drug Manufacturers - Specialty & Generic -7.53% -8.18% Boiron S.A
BOI468.55M Healthcare Drug Manufacturers - Specialty & Generic -16.48% -43.16% Euroapi S.A.S.U
EAPI312.68M Healthcare Drug Manufacturers - Specialty & Generic -9.64% -81.18% AB Science S.A
AB85.89M Healthcare Drug Manufacturers - Specialty & Generic 33.33% -82.83% CoreTech Limited
MLCOT2.18M Healthcare Drug Manufacturers - Specialty & Generic 550.00% 225.00% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Ipsen S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Ipsen S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 10.89%, the Debt to Equity ratio from the most recent quarter is 22.74, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for IPN?
- Looking at Ipsen S.A's growth, its revenue over the trailing twelve months (TTM) was €4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.60%, and quarterly earnings saw a YoY growth of 44.00%.
- How much of IPN stock is held by insiders and institutions?
- Wondering who owns Ipsen S.A stock? Company insiders (like executives and directors) hold about 57.22% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 15.31%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.